leqephe_banner

lihlahisoa

Prostaglandins Chemical sehlahisoa 99%purity API Material Lumigan Bimatoprost CAS 155206-00-1 bakeng sa ho phekola mahlo

tlhaloso e khuts'oane:


  • Tekano:1.1 ± 0.1 g/cm3
  • Sebaka se belang:629.8 ± 55.0 ° C AT 760 mmHg
  • Sebaka sa ho qhibiliha:66-68 ° C
  • Molek'hule:C25H37NO4
  • Boima ba molek'hule:415.566
  • Flash point:334.7 ± 31.5 ° C
  • Boleng bo Nepahetseng:415.272247
  • PSA:89.79000
  • Logp:1.98
  • Ponahalo:Crystal e tiileng, phofo
  • Khatello ea mouoane:0.0 ± 1.9 mmHg KA 25 ° C
  • Lenane la Refractive:1.591
  • Lintlha tsa Sehlahisoa

    Li-tag tsa Sehlahisoa

    Ikopanye le 'na

    Email:ceo66@hbainuodi.com

    Whtasapp:+8618849057872

    Wickr: alice868

    Tšebeliso

    Bimatoprost ke sethethefatsi sa prostaglandin se qalileng ho sebelisoa ho phekola mafu a mahlo a kang glaucoma.Lebitso la lithethefatsi ke Lumigan.Leha ho le joalo, nakong ea phekolo, mokuli o ile a fumana ka tšohanyetso hore bophara, bolelele le boima ba li-eyelashes tsa hae li eketsehile haholo.Kamora moo, bimatoprost e ile ea sebelisoa litekong tsa bongaka bakeng sa botle ba lintši.Phello ea eona e kholo ea li-eyelashes tse teteaneng le tse teteaneng ka ho toba li lebisitse ho qalisoa ha Lattise ke k'hamphani ea tlhahiso ea Lumegen, Allergan.Setlhare sena se ile sa qalisoa ka December 2008. E amohetsoe ke US FDA, e fetohile sehlahisoa sa setsebi bakeng sa ho ntšoa le ho teteka ha li-eyelashes.

    Ka July 2006, marotholi a mahlo a bimatoprost-timolol maleate a kopantsoeng a entsoeng ke United States Allergan Co., Ltd. e ile ea amoheloa ke bolaoli ba meriana ea EU bakeng sa ho fokotsa karabelo ea tšebeliso e le 'ngoe ea li-β-receptor blockers kapa prostaglandins.Khatello ea methapo ea methapo kapa khatello ea mali ea mahlo ho bakuli ba nang le glaucoma e bulehileng ba sa arabeleng ka mokhoa o lekaneng kalafong ea analog.Marotholi a mahlo a kopantsoeng a na le 0.0Chemicalbook3% bimatoprost le 0.5% timolol maleate, hanngoe ka letsatsi, e ka fana ka phello ea kliniki e sebetsang haholo ea khatello ea methapo ea methapo, 'me phello e molemo ho feta ea bimatoprost feela.Matoprost kapa timolol maleate.Liteko tsa bongaka li netefalitse hore moriana o na le mamello e ntle haholo, ho kenyelletsa le phokotso ea 40% ea sekhahla sa hyperemia ea mahlo ha e bapisoa le bimatoprost feela.
    Bakeng sa kalafo ea glaucoma, e ka sebelisoa hape ho mokelikeli oa kholo ea eyelash, mahloriso ke 0.03%

    Bimatoprost CAS 155206-00-1

    Litlhaloso

    Lebitso la Sehlahiswa Bimatoprost
    CAS 155206-00-1
    Botenya 1.1 ± 0.1 g/cm3
    Ntho e belang 629.8 ± 55.0 ° C AT 760 mmHg
    Sebaka se qhibilihang 66-68 ° C
    Molek'hule C25H37NO4
    Boima ba molek'hule 415.566
    flash point 334.7 ± 31.5 ° C
    Boleng bo Nepahetseng 415.272247
    PSA 89.79000
    Logp 1.98
    Ponahalo Crystal e tiileng
    Khatello ea mouoane 0.0 ± 1.9 mmHg KA 25 ° C
    Lenane la refractive 1.591
    Maemo a polokelo 20 ° C

    Lipatlisiso tse ling tsa Bimatoprost CAS 155206-00-1:

    Olaparib e ne e sebetsa kgahlanong le Brca1;p53 matsoele ente (50mg/kg intraperitoneal ente ka letsatsi), empa e ne e se na phello ho HR-deficient Ecad;p53 matsoele a matsoele.Olaparib e ne e se na chefo e fokotsang tekanyetso ho litoeba tse nang le tumor.Olaparib e 'nile ea sebelisoa ho phekola lihlahala ka liphetoho tsa BRCA, tse kang kankere ea mahe a bomme, mofetše oa matsoele le mofetše oa senya.Ho feta moo, Olaparib e ile ea thibela lisele tsa hlahala tse haelloang ke ATM ka mokhoa o ikhethileng, e fana ka maikutlo a hore Olaparib e ka sebelisoa e le moemeli oa kalafo ea lihlahala tsa lymphoid tse fetotsoeng ke ATM.
    Olaparib ke PARP inhibitor hape e sebetsa khahlano le liphetoho tsa BRCA1 kapa BRCA2.Olaparib e na le phello e fokolang ho tanky (polymer) enzyme-1, 'me boleng ba IC50 bo boholo ho feta moo.Olaparib sebakeng sa 30-100nM e sebetsa liseleng tsa SW620 ho etsa hore PARP-1 e sebetse.BRCA1-deficient cell line (MDA-MB-463[1] le HCC1937) e na le hypersensitive ho Olaparib ha e bapisoa le BRCA1- le BRCA2-sufficient cell line (Hs578T,MDA-MB-23,T47D) Olaparib e thibela PARP le ho thibela ho lokisoa ha motheo. , e hlahisang kutloisiso e matla ea lisele tsa KB2P ho Olaparib.Sephetho ke phetoho ea likheo tsa khoele e le 'ngoe ho ea ho likheo tse habeli nakong ea phetisetso ea DNA, ka hona ho kenya tšebetsong tsela ea ho kopanya e itšetlehileng ka BRCA2.
    Bimatoprost ke motsoako oa prostamide F2α, o ka khethang ho etsisa phello ea prostamine e hlahisoang 'meleng, ho eketsa sekhahla sa tlhahiso ea metlae ea metsi, ho fokotsa khanyetso ea metsi a monate, le ho eketsa mocha oa marang-rang oa trabecular le uveal sclera. e be sethethefatsi sa lehae sa anti-glaucoma se nang le phello e matla ho fokotsa khatello ea methapo ea kutlo.E loketse bakeng sa kalafo ea open-angle glaucoma (POAG) kapa mahlo a phahameng a sa sebetseng le lithethefatsi tse ling tsa intraocular tse theolang khatello.Bakuli ba khatello ea mali (OHT).

    Ela hloko:

    Haeba u thahasella, ka kopo ikopanye le rona ka bolokolohi, re tla araba ka nako.Hope re na le tšebelisano.


    Ngola molaetsa wa hao mona mme o re romele wona